Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine
Published by Logos Press, and available nationwide through Barnes & Noble, Amazon.com, Borders Books, and other booksellers, Get Market Now! (342 pages, ISBN: 978-1-934899-12-0, softcover) is designed for executives in the life sciences, from pharmaceutical and biotechnology firms, to medical device and diagnostic companies.
Readers of advanced copies have also suggested the book will be “an excellent resource for investors and venture capitalists who need to accurately assess if a company has what it takes in its research & development programs to succeed over the next ten years.”
The book provides practical strategies to speed time to market and simply FDA compliance supported with analyses, advice and more than:
• 25 figures, diagrams and tables
• 15 different checklists and templates
• 113 specific tactics
• 16 case studies and real-world examples
The book's readers also benefit from a dedicated book website - http://www.Get2MarketNow.com - full of downloadable templates, mini-tutorials, and more.
Early reviews have cited the book for how well its writing and organization make complex, nuanced subjects easy to understand, from tackling the decline in new medicine innovation and R&D productivity, through increasing business flexibility while still complying with regulations.
Journalists who would like a review copy of Get to Market Now!, should contact the publisher Logos Press directly in Washington, D.C.: info@logos-press.com or 202-487-0089.
Author John Avellanet is the founder and Managing Director of Cerulean Associates LLC, a private regulatory compliance consultancy based in Williamsburg, Virginia. Mr. Avellanet has gained tremendous acclaim on his speeches, workshops and teleconferences for corporate clients and conference venues around the world. Enthusiastic testimonials from attendees cover his speaking page on his website. Conference organizers and program directors repeatedly note that he gets the highest evaluations of any of their speakers.
He serves on the boards of several industry associations, and is the FDA compliance columnist for several international industry journals. Every month, he publishes the regulatory intelligence and FDA quality systems advice newsletter for executives, SmarterCompliance™. Learn more about Mr. Avellanet on his award-winning blog, http://www.ComplianceZen.com. To engage his private consulting services for FDA-regulated firms, contact him through his company’s website: http://www.ceruleanllc.com
###